H. Gul

Design and biological evaluation of sulfonamide-chalcone hybrids with in vitro tumor-selective cytotoxicity against oral squamous cell carcinoma: SAR, QSAR, and in silico ADME studies.

Rational drug design for Alzheimer's disease: from approved therapies to next-generation clinical candidates and AI-guided innovation.

The incorporation of artificial intelligence (AI) and machine learning (ML) is expected to enhance the prediction of pharmacokinetic, pharmacodynamic, and toxicity parameters in AD drug design.